Company intelligence / Profile preview

Orchid Medical

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Orchid Health commercially offers whole-genome preimplantation and carrier genetic screening, primarily for IVF and family planning applications; clinical outcomes are not interventional but enable informed embryo selection to mitigate disease risk

Therapeutic areas: Women's HealthRare Diseases
Industry: Molecular Diagnostics

Partnerships

IVF clinics and fertility centersexpert geneticist advisors (e.g., George Church, Anne Wojcicki as investors/advisors)

Beyond the preview

Go deeper on Orchid Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orchid Medical.

Explore the full profile